Search results: Sage Journals

Available accessReview articleFirst published March, 2023

Inclisiran: A First-in-Class siRNA Therapy for Lowering Low-Density Lipoprotein Cholesterol

Essie Samuel, Maya Watford, Ugochukwu O. Egolum [...]

Annals of Pharmacotherapy

Open accessReview articleFirst published 2025

A Real-World Retrospective Analysis of Secondary Prevention Patients Treated with Inclisiran over 27 Months

Carl Deaney, Meredith Donaldson, Agne Meskauskiene

Clinical Medicine Insights: Cardiology

Open accessResearch articleFirst published 2024

Retrospective Evaluation of LDL-C Levels Following First Treatment With Inclisiran as Part of Secondary Prevention ASCVD Risk Reduction in a Real-World Primary Care Setting

Carl N. Deaney, Meredith P. Donaldson, Danielle M. Reesby [...]

Journal of Primary Care & Community Health

Available accessCase reportFirst published June, 2025

“Are new lipid lowering agents a good option for achieving lipid goals in people living with HIV? A case report”

Raffaele Ferri, Katia Falasca, Jacopo Vecchiet [...]

International Journal of STD & AIDS

Open accessEditorialFirst published December, 2024

Inclisiran in India: A Game-changer for Dyslipidemia Management

AN Patnaik

Indian Journal of Clinical Cardiology

Available accessResearch articleFirst published February, 2026

Class-Specific Adverse Events of Patients Treated with Small Interfering RNA Therapeutics: A Disproportionality Analysis of the United States Food and Drug Administration Adverse Event Reporting System Database Based on the MY FAERS Platform

Ze Li, Xiaozhen Wang, Dandan Li [...]

Nucleic Acid Therapeutics

Available accessReview articleFirst published June, 2019

Changes in circulating pro-protein convertase subtilisin/kexin type 9 levels – experimental and clinical approaches with lipid-lowering agents

C Macchi, M Banach, A Corsini [...]

European Journal of Preventive Cardiology

Open accessResearch articleFirst published 2023

Implementing an Innovative Lipid Management Technique Using siRNA LDL-C Lowering Therapy: Lessons Learned in an NHS Primary Care Practice With Worked Case Examples

Carl Deaney, Meredith Donaldson, Agne Meskauskiene

Journal of Primary Care & Community Health

Open accessReview articleFirst published 2026

Dyslipidemia in Diabetes: Navigating a Complex Landscape for Improved Cardiovascular Outcomes

Roshaida Abdul Wahab, Wan Aizad Wan Mahmood

Clinical Medicine Insights: Endocrinology and Diabetes

Available accessReview articleFirst published July, 2026

Dyslipidemia management in stroke prevention: An individualized approach

Maria-Ioanna Stefanou, Evangelos Panagiotopoulos, Evangelos Liberopoulos [...]

International Journal of Stroke

Available accessReview articleFirst published March, 2023

Inclisiran: A First-in-Class siRNA Therapy for Lowering Low-Density Lipoprotein Cholesterol

Essie Samuel, Maya Watford, Ugochukwu O. Egolum [...]

Annals of Pharmacotherapy

Open accessReview articleFirst published 2025

A Real-World Retrospective Analysis of Secondary Prevention Patients Treated with Inclisiran over 27 Months

Carl Deaney, Meredith Donaldson, Agne Meskauskiene

Clinical Medicine Insights: Cardiology

Open accessResearch articleFirst published 2024

Retrospective Evaluation of LDL-C Levels Following First Treatment With Inclisiran as Part of Secondary Prevention ASCVD Risk Reduction in a Real-World Primary Care Setting

Carl N. Deaney, Meredith P. Donaldson, Danielle M. Reesby [...]

Journal of Primary Care & Community Health

Available accessCase reportFirst published June, 2025

“Are new lipid lowering agents a good option for achieving lipid goals in people living with HIV? A case report”

Raffaele Ferri, Katia Falasca, Jacopo Vecchiet [...]

International Journal of STD & AIDS

Open accessEditorialFirst published December, 2024

Inclisiran in India: A Game-changer for Dyslipidemia Management

AN Patnaik

Indian Journal of Clinical Cardiology

Available accessResearch articleFirst published February, 2026

Class-Specific Adverse Events of Patients Treated with Small Interfering RNA Therapeutics: A Disproportionality Analysis of the United States Food and Drug Administration Adverse Event Reporting System Database Based on the MY FAERS Platform

Ze Li, Xiaozhen Wang, Dandan Li [...]

Nucleic Acid Therapeutics

Available accessReview articleFirst published June, 2019

Changes in circulating pro-protein convertase subtilisin/kexin type 9 levels – experimental and clinical approaches with lipid-lowering agents

C Macchi, M Banach, A Corsini [...]

European Journal of Preventive Cardiology

Open accessResearch articleFirst published 2023

Implementing an Innovative Lipid Management Technique Using siRNA LDL-C Lowering Therapy: Lessons Learned in an NHS Primary Care Practice With Worked Case Examples

Carl Deaney, Meredith Donaldson, Agne Meskauskiene

Journal of Primary Care & Community Health

Open accessReview articleFirst published 2026

Dyslipidemia in Diabetes: Navigating a Complex Landscape for Improved Cardiovascular Outcomes

Roshaida Abdul Wahab, Wan Aizad Wan Mahmood

Clinical Medicine Insights: Endocrinology and Diabetes

Available accessReview articleFirst published July, 2026

Dyslipidemia management in stroke prevention: An individualized approach

Maria-Ioanna Stefanou, Evangelos Panagiotopoulos, Evangelos Liberopoulos [...]

International Journal of Stroke